Literature DB >> 21080020

Supramolecular synthon pattern in solid clioquinol and cloxiquine (APIs of antibacterial, antifungal, antiaging and antituberculosis drugs) studied by ³⁵Cl NQR, ¹H-¹⁷O and ¹H-¹⁴N NQDR and DFT/QTAIM.

Jolanta Natalia Latosińska1, Magdalena Latosińska, Marzena Agnieszka Tomczak, Janez Seliger, Veselko Zagar.   

Abstract

The quinolinol derivatives n class="Chemical">clioquinol (5-chloro-7-iodo-8-quinolinol, Quinoform) and cloxiquine (5-chloro-8-quinolinol) were studied experimentally in the solid state via ³⁵Cl NQR, ¹H-¹⁷O and ¹H-¹⁴N NQDR spectroscopies, and theoretically by density functional theory (DFT). The supramolecular synthon pattern of O-H···N hydrogen bonds linking dimers and π-π stacking interactions were described within the QTAIM (quantum theory of atoms in molecules) /DFT (density functional theory) formalism. Both proton donor and acceptor sites in O-H···N bonds were characterized using ¹H-¹⁷O and ¹H-¹⁴N NQDR spectroscopies and QTAIM. The possibility of the existence of O-H···H-O dihydrogen bonds was excluded. The weak intermolecular interactions in the crystals of clioquinol and cloxiquine were detected and examined. The results obtained in this work suggest that considerable differences in the NQR parameters for the planar and twisted supramolecular synthons permit differentiation between specific polymorphic forms, and indicate that the more planar supramolecular synthons are accompanied by a greater number of weaker hydrogen bonds linking them and stronger π···π stacking interactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080020      PMCID: PMC3126996          DOI: 10.1007/s00894-010-0876-4

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  25 in total

1.  PROPHYLAXIS AND THERAPY OF AMEBIASIS AND SHIGELLOSIS WITH IODOCHLORHYDROXYQUIN.

Authors:  L M GHOLZ; W L ARONS
Journal:  Am J Trop Med Hyg       Date:  1964-05       Impact factor: 2.345

2.  Structure-activity study of thiazides by magnetic resonance methods (NQR, NMR, EPR) and DFT calculations.

Authors:  J N Latosińska
Journal:  J Mol Graph Model       Date:  2005-01       Impact factor: 2.518

3.  Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

Authors:  R A Cherny; C S Atwood; M E Xilinas; D N Gray; W D Jones; C A McLean; K J Barnham; I Volitakis; F W Fraser; Y Kim; X Huang; L E Goldstein; R D Moir; J T Lim; K Beyreuther; H Zheng; R E Tanzi; C L Masters; A I Bush
Journal:  Neuron       Date:  2001-06       Impact factor: 17.173

4.  In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis.

Authors:  Poonpilas Hongmanee; Kamolchanok Rukseree; Benjamas Buabut; Boontiwa Somsri; Prasit Palittapongarnpim
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

5.  Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.

Authors:  Trent Nguyen; Aaron Hamby; Stephen M Massa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

6.  How short can the H...H intermolecular contact be? New findings that reveal the covalent nature of extremely strong interactions.

Authors:  Sławomir J Grabowski; W Andrzej Sokalski; Jerzy Leszczynski
Journal:  J Phys Chem A       Date:  2005-05-19       Impact factor: 2.781

7.  Anticancer activity of the antibiotic clioquinol.

Authors:  Wei-Qun Ding; Bolin Liu; Joshua L Vaught; Hanako Yamauchi; Stuart E Lind
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

8.  Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol.

Authors:  M S Yassin; J Ekblom; M Xilinas; C G Gottfries; L Oreland
Journal:  J Neurol Sci       Date:  2000-02-01       Impact factor: 3.181

Review 9.  Metal-protein attenuating compounds and Alzheimer's disease.

Authors:  Craig W Ritchie; Ashley I Bush; Colin L Masters
Journal:  Expert Opin Investig Drugs       Date:  2004-12       Impact factor: 6.206

10.  Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

Authors:  Craig W Ritchie; Ashley I Bush; Andrew Mackinnon; Steve Macfarlane; Maree Mastwyk; Lachlan MacGregor; Lyn Kiers; Robert Cherny; Qiao-Xin Li; Amanda Tammer; Darryl Carrington; Christine Mavros; Irene Volitakis; Michel Xilinas; David Ames; Stephen Davis; Konrad Beyreuther; Rudolph E Tanzi; Colin L Masters
Journal:  Arch Neurol       Date:  2003-12
View more
  3 in total

1.  Single crystal architecture and absorption spectra of octathio[8]circulene and sym-tetraselenatetrathio[8]circulene: QTAIM and TD-DFT approach.

Authors:  Gleb V Baryshnikov; Boris F Minaev; Valentina A Minaeva; Valentine G Nenajdenko
Journal:  J Mol Model       Date:  2013-08-14       Impact factor: 1.810

2.  Cloxiquine, a traditional antituberculosis agent, suppresses the growth and metastasis of melanoma cells through activation of PPARγ.

Authors:  Wenxiang Zhang; Wei Shao; Zhewen Dong; Shiyao Zhang; Chang Liu; Siyu Chen
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

3.  Gelation Behavior of 5-Chloro-8-hydroxyquinoline, an Antituberculosis Agent in Aqueous Alcohol Solutions.

Authors:  Erkki Kolehmainen; Hannu Salo; Jukka Korpela
Journal:  Antibiotics (Basel)       Date:  2012-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.